CELENA CALPIN: Open Payments
NPI 1144738451 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 39 payments from 17 companies in 2025. Trend: 2023 $1,469 · 2024 $1,702 · 2025 $1,231
Food & beverage: $1,231
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $197 |
| Boston Scientific Corporation | 1 | $140 |
| Lilly USA, LLC | 2 | $138 |
| Alnylam Pharmaceuticals Inc. | 4 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| Novo Nordisk Inc | 4 | $79 |
| Amgen Inc. | 5 | $76 |
| Verona Pharma, Inc. | 1 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
Products named: FARXIGA, WATCHMAN FLX, MOUNJARO, UZEDY, Wegovy, REPATHA, ONPATTRO, Ohtuvayre.
Industry payments across PA — which companies pay providers there.
